BioAge Therapeutics
BioAge Therapeutics Raises $350M Series C to Transform Healthcare
Quick Facts
BioAge Therapeutics
Longevity biotechnology company developing therapies to reverse cellular aging and extend healthy human lifespan by 50+ years.
About the Funding
BioAge Therapeutics has successfully raised $350M in a Series C funding round, bringing their total valuation to $4.3B. This significant investment will fuel the company's mission to advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies.
Use of Funds
Advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies
Company Overview
Longevity biotechnology company developing therapies to reverse cellular aging and extend healthy human lifespan by 50+ years.
Key Investors
- • Genentech Ventures
- • Gilead Sciences
- • Andreessen Horowitz Bio Fund
- • Jeff Bezos
Founders
- • Dr. Sarah Longevity
- • Dr. James Youth
Previous Rounds
Market Impact
This funding round positions BioAge Therapeutics as a leader in the Biotech space, with the capital to accelerate innovation and expand their market presence. The investment reflects growing confidence in healthcare solutions and the company's potential to transform the industry.
Key Investors
About the Author
Related Company Reports
NanoMedicine Labs Raises $460M Series C to Transform Healthcare
NanoMedicine Labs secures $460M in Series C funding at $5.8B valuation to advance phase iii clinical trials, scale manufacturing capabilities, and expand pipeline to rare diseases.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
